Prostate Cancer - Results from #380

Survey on prostate MRI reading and interpretation among urology residents in Italy, Brazil and the UK: a cry for help. October 27, 2022

First communication on the efficacy of combined 177Lutetium-PSMA with immunotherapy outside prostate cancer. October 27, 2022

PSMA-PET Detection of Unusual Metastases in Castrate-Sensitive Prostate Carcinoma. October 27, 2022

Prostate cancer-related anxiety among long-term survivors after radical prostatectomy: A longitudinal study. October 27, 2022

Sequencing of Androgen-Deprivation Therapy With External-Beam Radiotherapy in Localized Prostate Cancer: A Phase III Randomized Controlled Trial. October 26, 2022

Role of MRI, Ultrasound, and Computed Tomography in the Management of Prostate Cancer. October 26, 2022

Selecting interventions for a psychosocial support program for prostate cancer patients undergoing active surveillance: A modified Delphi study. October 26, 2022

Radiologists' contribution to variation in detecting clinically significant prostate cancer in men with prostate MRI. October 26, 2022

Identification of a high-risk immunogenic prostate cancer patient subset as candidates for T-cell engager immunotherapy and the introduction of a novel albumin-fused anti-CD3 × anti-PSMA bispecific design. October 26, 2022

Incidence, prevalence, and treatment patterns in metastatic hormone-sensitive prostate cancer in Spain: ECHOS study. October 26, 2022

Feasibility of Global Assessment of Bone Metastases in Prostate Cancer with 18F-Sodium Fluoride-PET/Computed Tomography. October 25, 2022

Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984. October 25, 2022

Prevalence of multimorbidity in men of African descent with and without prostate cancer in Soweto, South Africa. October 25, 2022

Phase II trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody Armed Activated T Cells in Metastatic Castrate Resistant Prostate Cancer. October 25, 2022

The Association between Financial Toxicity and Treatment Regret in Men with Localized Prostate Cancer. October 25, 2022

Ga-68 Prostate-Specific Membrane Antigen PET/CT: Imaging and Clinical Perspective in Prostate Cancer: Imaging and Clinical Perspective in Prostate Cancer. October 24, 2022

Prostate Cancer Imaging with 18F-Fluciclovine. October 24, 2022

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer. October 24, 2022

PSA testing behaviors for prostate cancer screening among U.S. immigrants: a cross-sectional analysis using the NHIS. October 24, 2022

Development of binational radiation therapy quality indicator reports for prostate cancer treatment using registry data. October 24, 2022

Page 20 of 1275

email news signup